ID   GBM-18
AC   CVCL_S551
SY   G-7
DR   Wikidata; Q54835466
RX   PubMed=1653364;
RX   PubMed=2839097;
CC   Derived from site: In situ; Brain; UBERON=UBERON_0000955.
DI   NCIt; C3058; Glioblastoma
DI   ORDO; Orphanet_360; Glioblastoma
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Sex unspecified
AG   Age unspecified
CA   Cancer cell line
DT   Created: 03-02-14; Last updated: 29-06-23; Version: 9
//
RX   PubMed=1653364; DOI=10.1093/jnci/83.18.1307;
RA   Reddy P.G., Graham G.M., Datta S., Guarini L., Moulton T.A.,
RA   Jiang H.-P., Gottesman M.M., Ferrone S., Fisher P.B.;
RT   "Effect of recombinant fibroblast interferon and recombinant immune
RT   interferon on growth and the antigenic phenotype of multidrug-resistant
RT   human glioblastoma multiforme cells.";
RL   J. Natl. Cancer Inst. 83:1307-1315(1991).
//
RX   PubMed=2839097;
RA   Vita J.R., Edwalds G.M., Gorey T., Housepian E.M., Fetell M.R.,
RA   Guarini L., Langer J.A., Fisher P.B.;
RT   "Enhanced in vitro growth suppression of human glioblastoma cultures
RT   treated with the combination of recombinant fibroblast and immune
RT   interferons.";
RL   Anticancer Res. 8:297-302(1988).
//